Power Law company profile

Nanobiotix

Biotech & Life Sciences · Paris, France · Founded 2003 · IPO 2012 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.65B

Market cap · Apr/2026

Revenue

$33M

Latest reported FY

Investors

4 investors on Nanobiotix's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

Karista

Series B+ 3 investors entered at this stage

OTC Asset Management

Crédit Mutuel Equity

Seventure Partners

Global footprint

Where Nanobiotix has talent and traffic

AI talent share

1.4% of workforce is AI talent
(2 of 143 staff)

Core AI10.7%

Other AI10.7%

Non-AI workforce14198.6%

Web traffic by country

12K monthly visits
across markets

🇺🇸 United States30%

🇫🇷 France30%

🇵🇭 Philippines28.3%

🇩🇪 Germany8.3%

🇮🇳 India5%

Top 5 markets shown

Patent intelligence

$95M patent portfolio · 36 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$95M

5.8% of market cap · 8.2× smaller than top peer BioNTech ($780M)

36 active patent families

Where Nanobiotix innovates Biocompatible nanoparticlesPharmaceutical drugBiological organismBiocompatibilityNanoparticle

Above peer median on Legal, Market

Quality vs same-sector peers

Nanobiotix on the five Patsnap quality dimensions

Nanobiotix in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Nanobiotix concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Nanobiotix and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Nanobiotix on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo